Home / EPRX.TO : TSX

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does EPRX.TO make money? Does EPRX.TO have pricing power? What's the Earnings Whisper? Will EPRX.TO profit more as the business scales? What is EPRX.TO's management track record? Is EPRX.TO's current price justified?

Eupraxia Pharmaceuticals Inc.

CAD 11.21 +$0.75 (+7.17%)

TSX · 14 Sep 2026 20:00 UTC

Previous Close

CAD 11.69

Day Range

CAD 11.13CAD 11.71

Year Range

CAD 7.15CAD 12.86

Market Cap

402.86M

AVG Volume

64.48K

Trailing/Forward PE

-7.91/-

PEG ratio

-0.55

Dividend Yield

Next Earnings Date

2026-11-03

Primary Exchange

Toronto Stock Exchange

Net Income (USD)

EPRX.TO Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-14.11M
26 Q1	-12.45M
25 Q4	-16.97M
25 Q3	-6.36M
25 Q2	-8.74M
25 Q1	-6.76M
24 Q4	-7.5M
24 Q3	-5.94M
24 Q2	-4.39M
24 Q1	-6M

Operating Income (USD)

EPRX.TO Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-17.64M
26 Q1	-15.7M
25 Q4	-16.41M
25 Q3	-6.88M
25 Q2	-8.26M
25 Q1	-7.12M
24 Q4	-7.48M
24 Q3	-6.27M
24 Q2	-6.56M
24 Q1	-6.65M

EBITDA (USD)

EPRX.TO EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	-17.5M
26 Q1	-15.61M
25 Q4	-16.34M
25 Q3	-6.31M
25 Q2	-6.38M
25 Q1	-4.72M
24 Q4	-7.48M
24 Q3	-4.39M
24 Q2	-4.2M
24 Q1	-5.75M

Cash Flows (USD)

EPRX.TO Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	-12.91M
26 Q1	-10.3M
25 Q4	-10.08M
25 Q3	-3.27M
25 Q2	-8.48M
25 Q1	-6.17M
24 Q4	-6.02M
24 Q3	-7.54M
24 Q2	-7.72M
24 Q1	-6.08M

EPS (USD)

EPRX.TO EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-0.23
26 Q1	-0.23
25 Q4	-0.34
25 Q3	-0.19
25 Q2	-0.26
25 Q1	-0.21
24 Q4	-0.22
24 Q3	-0.13
24 Q2	-0.12
24 Q1	-0.21

Expenses (USD)

EPRX.TO Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	17.67M
26 Q1	16.03M
25 Q4	16.42M
25 Q3	6.91M
25 Q2	6.23M
25 Q1	5.17M
24 Q4	5.24M
24 Q3	4.65M
24 Q2	4.81M
24 Q1	6.62M

Cash & Debt (USD)

EPRX.TO Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	133.44M
26 Q1	138.98M
25 Q4	80.42M
25 Q3	88.75M
25 Q2	19.77M
25 Q1	27.45M
24 Q4	33.1M
24 Q3	6.38M
24 Q2	23.34M
24 Q1	35.78M

Debt ratios

EPRX.TO Debt ratios by quarter
Period	Debt ratios
26 Q2	2.36
26 Q1	3.07
25 Q4	2.38
25 Q3	3.56
25 Q2	0.86
25 Q1	1.32
24 Q4	1.51
24 Q3	0.28
24 Q2	0.89
24 Q1	0.96

Return on Capital

EPRX.TO Return on Capital by quarter
Period	Return on Capital
26 Q2	-10.9%
26 Q1	-9.13%
25 Q4	-21.13%
25 Q3	-7.21%
25 Q2	-41.67%
25 Q1	-25.02%
24 Q4	-23.56%
24 Q3	-74.5%
24 Q2	-32.94%
24 Q1	-33.26%

Shares Outstanding

EPRX.TO Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	66.22M
26 Q1	56.71M
25 Q4	51.94M
25 Q3	33.48M
25 Q2	35.91M
25 Q1	35.69M
24 Q4	35.64M
24 Q3	35.62M
24 Q2	35.62M
24 Q1	28.81M

Book Value Per Share (USD)

EPRX.TO Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	1.95
26 Q1	2.4
25 Q4	1.55
25 Q3	2.64
25 Q2	0.58
25 Q1	0.76
24 Q4	0.89
24 Q3	0.22
24 Q2	0.37
24 Q1	0.63

Total Assets (USD)

EPRX.TO Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	139.68M
26 Q1	145.46M
25 Q4	85.99M
25 Q3	92.13M
25 Q2	23.6M
25 Q1	29.23M
24 Q4	34.94M
24 Q3	10.36M
24 Q2	25M
24 Q1	36.51M

Free Cash Flow Yield

EPRX.TO Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-6.72%
Sep 26	-6.73%
Aug 26	-8.49%
Aug 26	-8.39%
Aug 26	-8.44%
Aug 26	-8.35%
Jul 26	-8.84%
Jul 26	-9.72%
Jul 26	-8.57%
Jul 26	-8.48%
Jul 26	-8.45%
Jun 26	-8.16%
Jun 26	-8.42%
Jun 26	-8.93%
Jun 26	-9.02%
May 26	-7.49%
May 26	-7.68%
May 26	-7.77%
May 26	-7.15%
May 26	-6.82%
Apr 26	-7.46%
Apr 26	-7.58%
Apr 26	-7.84%
Apr 26	-7.54%
Mar 26	-10.67%
Mar 26	-10.02%
Mar 26	-9.67%
Mar 26	-8.89%
Feb 26	-8.76%
Feb 26	-8.37%
Feb 26	-8.48%
Feb 26	-8.53%
Jan 26	-8.66%
Jan 26	-7.93%
Jan 26	-8.13%
Jan 26	-8.84%
Jan 26	-9.39%
Dec 25	-9.76%
Dec 25	-10.83%
Dec 25	-11.41%
Dec 25	-11.57%
Nov 25	-11.44%
Nov 25	-11.35%
Nov 25	-10.78%
Nov 25	-13.08%
Oct 25	-13.75%
Oct 25	-14.37%
Oct 25	-13.56%
Oct 25	-13.09%
Oct 25	-13.47%
Sep 25	-13.42%
Sep 25	-12.87%
Sep 25	-14.48%
Sep 25	-14.42%
Aug 25	-14.24%
Aug 25	-14.5%
Aug 25	-14.41%
Aug 25	-14.67%
Aug 25	-14.48%
Jul 25	-13.95%
Jul 25	-14.65%
Jul 25	-13.79%
Jul 25	-13.67%
Jun 25	-14.28%
Jun 25	-17.48%
Jun 25	-19.48%
Jun 25	-19.79%
May 25	-19.74%
May 25	-20.03%
May 25	-20.04%
May 25	-19.8%
May 25	-19.24%
Apr 25	-19.9%
Apr 25	-23.28%
Apr 25	-25.7%
Apr 25	-26.31%
Mar 25	-23.08%
Mar 25	-20.98%
Mar 25	-18.47%
Mar 25	-18.34%
Feb 25	-19.47%
Feb 25	-20.66%
Feb 25	-24.02%
Feb 25	-23.83%
Jan 25	-25.05%
Jan 25	-25.3%
Jan 25	-24%
Jan 25	-25.61%
Jan 25	-25.25%
Dec 24	-25.01%
Dec 24	-25.86%
Dec 24	-22.86%
Dec 24	-25.01%
Nov 24	-22.87%
Nov 24	-22.18%
Nov 24	-25.06%
Nov 24	-24.62%
Nov 24	-25.27%
Oct 24	-31.55%
Oct 24	-30.72%

Price to Book

EPRX.TO Price to Book by quarter
Period	Price to Book
Sep 26	3.51
Sep 26	3.5
Aug 26	2.78
Aug 26	2.81
Aug 26	2.79
Aug 26	2.82
Jul 26	2.67
Jul 26	2.43
Jul 26	2.75
Jul 26	2.78
Jul 26	2.79
Jun 26	4.28
Jun 26	4.14
Jun 26	3.91
Jun 26	3.87
May 26	4.66
May 26	4.54
May 26	4.49
May 26	4.88
May 26	5.12
Apr 26	4.68
Apr 26	4.6
Apr 26	4.45
Apr 26	4.62
Mar 26	2.54
Mar 26	2.71
Mar 26	2.81
Mar 26	3.05
Feb 26	3.1
Feb 26	3.24
Feb 26	3.2
Feb 26	3.18
Jan 26	3.14
Jan 26	3.42
Jan 26	3.34
Jan 26	3.07
Jan 26	2.89
Dec 25	2.78
Dec 25	2.51
Dec 25	2.38
Dec 25	2.35
Nov 25	2.37
Nov 25	2.39
Nov 25	2.52
Nov 25	2.07
Oct 25	9.78
Oct 25	9.36
Oct 25	9.92
Oct 25	10.27
Oct 25	9.98
Sep 25	7.57
Sep 25	7.89
Sep 25	7.01
Sep 25	7.04
Aug 25	7.13
Aug 25	7
Aug 25	7.04
Aug 25	6.92
Aug 25	7.01
Jul 25	7.28
Jul 25	6.93
Jul 25	7.36
Jul 25	7.43
Jun 25	6.02
Jun 25	4.92
Jun 25	4.41
Jun 25	4.34
May 25	4.35
May 25	4.29
May 25	4.29
May 25	4.34
May 25	4.47
Apr 25	4.32
Apr 25	3.69
Apr 25	3.34
Apr 25	3.27
Mar 25	14.85
Mar 25	16.34
Mar 25	18.55
Mar 25	18.69
Feb 25	17.6
Feb 25	16.59
Feb 25	14.27
Feb 25	14.38
Jan 25	13.68
Jan 25	13.55
Jan 25	14.28
Jan 25	13.38
Jan 25	13.57
Dec 24	8.32
Dec 24	8.05
Dec 24	9.1
Dec 24	8.32
Nov 24	9.1
Nov 24	9.39
Nov 24	8.31
Nov 24	8.45
Nov 24	8.24
Oct 24	6.6
Oct 24	6.78

No video analysis for this stock yet. Request one from our team.

AI Analysis

Eupraxia Pharmaceuticals Inc.

Video analysis: EPRX.TO

Similar companies